• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自发性蛛网膜下腔出血后病死率和功能结局:基于人群的研究中时间趋势和地域差异的系统评价和荟萃分析。

Case fatality and functional outcome after spontaneous subarachnoid haemorrhage: A systematic review and meta-analysis of time trends and regional variations in population-based studies.

机构信息

Department of Neurosurgery, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Department of Neurosurgery, University Medical Center Ulm, Günzburg, Germany.

出版信息

Eur Stroke J. 2024 Sep;9(3):555-565. doi: 10.1177/23969873241232823. Epub 2024 Feb 14.

DOI:10.1177/23969873241232823
PMID:38353205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418425/
Abstract

INTRODUCTION

A previous systematic review of population-based studies from 1973 to 2002 found a decrease in case fatality for spontaneous subarachnoid haemorrhage, but could not find a sufficient number of studies to assess changes in functional outcome. Since then, treatment has advanced distinctly. We assessed whether case fatality has decreased further and whether functional outcome has improved.

PATIENTS AND METHODS

We searched PubMed and Web of Science for new population-based studies using the same criteria as in our previous systematic review. We assessed changes in case fatality and functional outcome over time using linear regression.

RESULTS

We included 24 new studies with 827 patients and analysed 9542 patients described in 62 study periods between 1973 and 2017. Case fatality decreased by 0.3% (95% CI: -0.7 to 0.1) per year. In a sensitivity analysis excluding studies that did not provide 1-month outcome and outliers, the age and sex-adjusted decrease was 0.1% per year (95% CI: -0.9 to 0.6). The mean case fatality rate decreased from 47% (95% CI: 31-63) in the 1970s to 35% (95% CI: 30-39) in the 1990s, and remained stable in the 2000s (34%; 95% CI: 27-41) and 2010s (38%; 95% CI: 15-60). In 15 studies, the mean proportion of patients living independently increased by 0.2% per year (95%CI: -0.7 to 1.1) and the mean was 45% (95% CI: 39-50) in six studies that reported outcome after 12 months.

DISCUSSION AND CONCLUSION

From 1973 to 2017, the case-fatality rate of spontaneous subarachnoid haemorrhage declined overall by 13.5%, but remained stable over the last two decades. The data on time trends in functional outcome were inconclusive.

摘要

介绍

先前对 1973 年至 2002 年的基于人群的研究进行的系统评价发现,自发性蛛网膜下腔出血的病死率有所下降,但无法找到足够数量的研究来评估功能结局的变化。此后,治疗明显取得了进展。我们评估病死率是否进一步下降,以及功能结局是否改善。

患者和方法

我们在 PubMed 和 Web of Science 上检索了使用与我们先前系统评价相同标准的新的基于人群的研究。我们使用线性回归来评估随时间变化的病死率和功能结局的变化。

结果

我们纳入了 24 项新的研究,其中包含 827 例患者,分析了 1973 年至 2017 年 62 个研究期间描述的 9542 例患者。病死率每年下降 0.3%(95%CI:-0.7 至 0.1)。在排除未提供 1 个月结局和异常值的研究的敏感性分析中,年龄和性别调整后的下降率为每年 0.1%(95%CI:-0.9 至 0.6)。平均病死率从 20 世纪 70 年代的 47%(95%CI:31-63)降至 90 年代的 35%(95%CI:30-39),在 2000 年代和 2010 年代保持稳定(分别为 34%;95%CI:27-41 和 38%;95%CI:15-60)。在 15 项研究中,每年独立生活的患者比例平均增加 0.2%(95%CI:-0.7 至 1.1),在 6 项报告 12 个月后结局的研究中,平均比例为 45%(95%CI:39-50)。

讨论和结论

1973 年至 2017 年,自发性蛛网膜下腔出血的病死率总体下降了 13.5%,但在过去二十年中保持稳定。关于功能结局的时间趋势数据尚无定论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9feb/11418425/b80e81891369/10.1177_23969873241232823-img3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9feb/11418425/b80e81891369/10.1177_23969873241232823-img3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9feb/11418425/b80e81891369/10.1177_23969873241232823-img3.jpg

相似文献

1
Case fatality and functional outcome after spontaneous subarachnoid haemorrhage: A systematic review and meta-analysis of time trends and regional variations in population-based studies.自发性蛛网膜下腔出血后病死率和功能结局:基于人群的研究中时间趋势和地域差异的系统评价和荟萃分析。
Eur Stroke J. 2024 Sep;9(3):555-565. doi: 10.1177/23969873241232823. Epub 2024 Feb 14.
2
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.根据年龄、性别和地区,动脉瘤性蛛网膜下腔出血的病死率随时间的变化:一项荟萃分析。
Lancet Neurol. 2009 Jul;8(7):635-42. doi: 10.1016/S1474-4422(09)70126-7. Epub 2009 Jun 6.
3
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.蛛网膜下腔出血后的病死率和功能转归:一项系统评价
Stroke. 1997 Mar;28(3):660-4. doi: 10.1161/01.str.28.3.660.
4
Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review.蛛网膜下腔出血结局的时间趋势:基于人群的研究和系统评价。
Neurology. 2010 May 11;74(19):1494-501. doi: 10.1212/WNL.0b013e3181dd42b3. Epub 2010 Apr 7.
5
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.根据年龄、性别和种族,随时间推移的脑出血发病率、病死率和功能结局:系统评价和荟萃分析。
Lancet Neurol. 2010 Feb;9(2):167-76. doi: 10.1016/S1474-4422(09)70340-0. Epub 2010 Jan 5.
6
Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT).颅内出血(SAH)国际卒中预后研究(INSTRUCT)后的病死率和功能结局。
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106201. doi: 10.1016/j.jstrokecerebrovasdis.2021.106201. Epub 2021 Nov 15.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
The falling rates of hospital admission, case fatality, and population-based mortality for subarachnoid hemorrhage in England, 1999-2010.1999-2010 年英格兰蛛网膜下腔出血的住院率、病死率和基于人群的死亡率下降。
J Neurosurg. 2016 Sep;125(3):698-704. doi: 10.3171/2015.5.JNS142115. Epub 2016 Jan 1.
9
Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage.血管内栓塞术与神经外科夹闭术治疗动脉瘤性蛛网膜下腔出血患者的比较。
Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD003085. doi: 10.1002/14651858.CD003085.pub3.
10
Incidence and case fatality of subarachnoid haemorrhage in Northern Greece: the Evros Registry of Subarachnoid Haemorrhage.希腊北部蛛网膜下腔出血的发病率和病死率:埃夫罗斯蛛网膜下腔出血登记处
Int J Stroke. 2009 Oct;4(5):322-7. doi: 10.1111/j.1747-4949.2009.00334.x.

引用本文的文献

1
Eighteen-Year Trends in Subarachnoid Hemorrhage Management and Outcomes: A Single-Center Experience.蛛网膜下腔出血的管理与结局的18年趋势:单中心经验
Neurocrit Care. 2025 Apr 28. doi: 10.1007/s12028-025-02268-3.
2
Modifiable Risk Factors for Subarachnoid Hemorrhage: Narrative Review With an Emphasis on Common Controversies and Epidemiologic Pitfalls.可改变的蛛网膜下腔出血风险因素:着重于常见争议和流行病学陷阱的叙述性综述。
Neurology. 2024 Dec 10;103(11):e210052. doi: 10.1212/WNL.0000000000210052. Epub 2024 Nov 18.
3
Circulating collagen breakdown products as a biomarker for presence and instability of human intracranial aneurysms.

本文引用的文献

1
Clinical Outcomes of Diffuse Angiogram-Negative Subarachnoid Hemorrhage Versus Aneurysmal Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis.弥散性血管造影阴性蛛网膜下腔出血与动脉瘤性蛛网膜下腔出血的临床转归:倾向评分匹配分析。
J Am Heart Assoc. 2024 Jan 2;13(1):e031066. doi: 10.1161/JAHA.123.031066. Epub 2023 Dec 29.
2
Case Fatality Rates of Subarachnoid Hemorrhage Are Decreasing with Substantial between-Country Variation: A Systematic Review of Population-Based Studies between 1980 and 2020.蛛网膜下腔出血的病死率呈下降趋势,但国家间差异较大:1980 年至 2020 年期间基于人群的研究的系统评价。
Neuroepidemiology. 2022;56(6):402-412. doi: 10.1159/000526983. Epub 2022 Oct 25.
3
循环中的胶原蛋白分解产物作为人类颅内动脉瘤存在及不稳定性的生物标志物。
Eur Stroke J. 2024 Nov 16:23969873241300057. doi: 10.1177/23969873241300057.
4
Trajectory of mean platelet volume changes after aneurysmal subarachnoid hemorrhage in patients with or without delayed cerebral ischemia.动脉瘤性蛛网膜下腔出血患者有无迟发性脑缺血时血小板平均体积变化的轨迹。
Sci Rep. 2024 Oct 24;14(1):25122. doi: 10.1038/s41598-024-75587-8.
Case Fatality in Patients With Aneurysmal Subarachnoid Hemorrhage in Finland: A Nationwide Register-Based Study.
芬兰动脉瘤性蛛网膜下腔出血患者的病死率:一项基于全国登记的研究。
Neurology. 2023 Jan 17;100(3):e348-e356. doi: 10.1212/WNL.0000000000201402. Epub 2022 Oct 18.
4
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up.2019冠状病毒病大流行对蛛网膜下腔出血住院治疗、动脉瘤治疗及住院死亡率的全球影响:1年随访
J Neurol Neurosurg Psychiatry. 2022 Jul 28. doi: 10.1136/jnnp-2022-329200.
5
Aneurysmal subarachnoid hemorrhage in Germany between 2005 and 2018: A nationwide observational study.2005 年至 2018 年德国的颅内动脉瘤性蛛网膜下腔出血:一项全国性观察性研究。
Eur J Neurol. 2022 Oct;29(10):3009-3016. doi: 10.1111/ene.15457. Epub 2022 Jul 5.
6
Incidence, risk factors, prognosis, and health-related quality of life after stroke in a low-resource community in Chile (ÑANDU): a prospective population-based study.智利低资源社区卒中的发生率、风险因素、预后和与健康相关的生活质量(ÑANDU):一项基于人群的前瞻性研究。
Lancet Glob Health. 2021 Mar;9(3):e340-e351. doi: 10.1016/S2214-109X(20)30470-8. Epub 2021 Jan 7.
7
Secular Trends of Stroke Epidemiology in Örebro, Sweden, 2017 Compared to the Trends in 1999: A Population-Based Study.瑞典厄勒布鲁 2017 年与 1999 年的卒中流行趋势的人群研究:时间趋势分析。
Cerebrovasc Dis. 2019;48(3-6):149-156. doi: 10.1159/000504082. Epub 2019 Nov 1.
8
Trends in the Incidence and Mortality of Stroke in Matão, Brazil: The Matão Preventing Stroke (MAPS) Study.巴西马陶的卒中发病率和死亡率趋势:马陶预防卒中(MAPS)研究。
Neuroepidemiology. 2020;54(1):75-82. doi: 10.1159/000503005. Epub 2019 Oct 4.
9
In Reply: Outcome After Clipping and Coiling for Aneurysmal Subarachnoid Hemorrhage in Clinical Practice in Europe, USA, and Australia.回复:欧洲、美国和澳大利亚临床实践中动脉瘤性蛛网膜下腔出血夹闭术和栓塞术后的结果。
Neurosurgery. 2019 Jun 1;84(6):E447. doi: 10.1093/neuros/nyz061.
10
Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis.根据地域、时间段、人群血压和吸烟率分析世界范围内的颅内动脉瘤性蛛网膜下腔出血发病率:系统评价和荟萃分析。
JAMA Neurol. 2019 May 1;76(5):588-597. doi: 10.1001/jamaneurol.2019.0006.